• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解中草药与肠道微生物群相互作用的分子机制。

Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota.

机构信息

School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.

Department of Pharmaceutical Analysis, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, P.R. China.

出版信息

Med Res Rev. 2017 Sep;37(5):1140-1185. doi: 10.1002/med.21431. Epub 2017 Jan 4.

DOI:10.1002/med.21431
PMID:28052344
Abstract

Herbal medicines (HMs) are much appreciated for their significant contribution to human survival and reproduction by remedial and prophylactic management of diseases. Defining the scientific basis of HMs will substantiate their value and promote their modernization. Ever-increasing evidence suggests that gut microbiota plays a crucial role in HM therapy by complicated interplay with HM components. This interplay includes such activities as: gut microbiota biotransforming HM chemicals into metabolites that harbor different bioavailability and bioactivity/toxicity from their precursors; HM chemicals improving the composition of gut microbiota, consequently ameliorating its dysfunction as well as associated pathological conditions; and gut microbiota mediating the interactions (synergistic and antagonistic) between the multiple chemicals in HMs. More advanced experimental designs are recommended for future study, such as overall chemical characterization of gut microbiota-metabolized HMs, direct microbial analysis of HM-targeted gut microbiota, and precise gut microbiota research model development. The outcomes of such research can further elucidate the interactions between HMs and gut microbiota, thereby opening a new window for defining the scientific basis of HMs and for guiding HM-based drug discovery.

摘要

草药(HMs)通过对疾病的治疗和预防管理,为人类的生存和繁衍做出了巨大贡献,深受人们的赞赏。定义草药的科学基础将证实其价值,并促进其现代化。越来越多的证据表明,肠道微生物群通过与草药成分的复杂相互作用,在草药治疗中起着至关重要的作用。这种相互作用包括以下活动:肠道微生物群将草药中的化学物质生物转化为代谢物,这些代谢物与其前体相比具有不同的生物利用度和生物活性/毒性;草药化学物质改善肠道微生物群的组成,从而改善其功能障碍以及相关的病理状况;肠道微生物群介导草药中多种化学物质之间的相互作用(协同和拮抗)。建议未来的研究采用更先进的实验设计,例如对肠道微生物群代谢的草药进行全面的化学特征分析、对草药靶向肠道微生物群进行直接微生物分析,以及开发精确的肠道微生物群研究模型。这些研究的结果可以进一步阐明草药与肠道微生物群之间的相互作用,从而为定义草药的科学基础和指导基于草药的药物发现开辟新的途径。

相似文献

1
Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota.理解中草药与肠道微生物群相互作用的分子机制。
Med Res Rev. 2017 Sep;37(5):1140-1185. doi: 10.1002/med.21431. Epub 2017 Jan 4.
2
Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.肠道微生物群、宿主和草药之间的相互作用:对 2 型糖尿病发病机制和治疗的新见解的综述。
Front Cell Infect Microbiol. 2020 Jul 17;10:360. doi: 10.3389/fcimb.2020.00360. eCollection 2020.
3
Gut microbial transformation, a potential improving factor in the therapeutic activities of four groups of natural compounds isolated from herbal medicines.肠道微生物转化,一种从草药中分离得到的四组天然化合物治疗活性的潜在改善因素。
Fitoterapia. 2019 Oct;138:104293. doi: 10.1016/j.fitote.2019.104293. Epub 2019 Aug 6.
4
Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?肠道微生物群能否解决传统草药口服生物利用度的难题?
J Ethnopharmacol. 2016 Feb 17;179:253-64. doi: 10.1016/j.jep.2015.12.031. Epub 2015 Dec 23.
5
Gut microbiota: A target for heavy metal toxicity and a probiotic protective strategy.肠道微生物群:重金属毒性的靶点和益生菌保护策略。
Sci Total Environ. 2020 Nov 10;742:140429. doi: 10.1016/j.scitotenv.2020.140429. Epub 2020 Jun 25.
6
The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders.肠道微生物群在欧盟传统用于治疗胃肠道疾病的药用植物活性中的作用。
J Ethnopharmacol. 2019 Dec 5;245:112153. doi: 10.1016/j.jep.2019.112153. Epub 2019 Aug 10.
7
Intestinal Microbiota-Associated Metabolites: Crucial Factors in the Effectiveness of Herbal Medicines and Diet Therapies.肠道微生物群相关代谢产物:草药和饮食疗法有效性的关键因素。
Front Physiol. 2019 Oct 29;10:1343. doi: 10.3389/fphys.2019.01343. eCollection 2019.
8
Regulation of Gut Microbiota by Herbal Medicines.草药对肠道微生物群的调节。
Curr Drug Metab. 2024;25(2):110-127. doi: 10.2174/0113892002287336240328083220.
9
The interplay between herbal medicines and gut microbiota in metabolic diseases.草药与肠道微生物群在代谢性疾病中的相互作用。
Front Pharmacol. 2023 Mar 24;14:1105405. doi: 10.3389/fphar.2023.1105405. eCollection 2023.
10
The interaction between the gut Microbiota and herbal medicines.肠道微生物群与草药的相互作用。
Biomed Pharmacother. 2019 Oct;118:109252. doi: 10.1016/j.biopha.2019.109252. Epub 2019 Aug 23.

引用本文的文献

1
Glycitin in Soy Beans: A Mine of Their Structures, Functions, and Potential Applications.大豆中的大豆黄素:其结构、功能及潜在应用宝库
Foods. 2025 Aug 23;14(17):2940. doi: 10.3390/foods14172940.
2
Maternal gut microbiota-derived daidzein prevents osteoporosis in female offspring following prenatal prednisone exposure.母体肠道微生物群衍生的大豆苷元可预防产前暴露于泼尼松的雌性后代患骨质疏松症。
Imeta. 2025 Apr 28;4(4):e70037. doi: 10.1002/imt2.70037. eCollection 2025 Aug.
3
Inter-species and individualized biotransformation of five saponins by human being- and mouse-derived fecal microbiota.
人源和鼠源粪便微生物群对五种皂苷的种间和个体化生物转化
Chin Med. 2025 Aug 25;20(1):132. doi: 10.1186/s13020-025-01190-2.
4
The effects of Shenkang suppository on kidney function and gut microbiota in nondialysis patients with chronic kidney disease stages 3-4: A randomized controlled trial.肾康栓对3-4期非透析慢性肾脏病患者肾功能及肠道微生物群的影响:一项随机对照试验
Front Pharmacol. 2025 Jul 29;16:1621208. doi: 10.3389/fphar.2025.1621208. eCollection 2025.
5
Bridging traditional Chinese medicine and Alzheimer's disease: the pivotal role of gut microbiota in multitarget therapeutic mechanisms.中医与阿尔茨海默病的桥梁:肠道微生物群在多靶点治疗机制中的关键作用
Front Pharmacol. 2025 Jun 27;16:1630205. doi: 10.3389/fphar.2025.1630205. eCollection 2025.
6
Efficient utilization of Shuanghuanglian medicine residues by microbial transformation with flavonoid glycosides-hydrolyzing strains.利用黄酮苷水解菌株通过微生物转化高效利用双黄连药渣。
Front Microbiol. 2025 May 27;16:1553399. doi: 10.3389/fmicb.2025.1553399. eCollection 2025.
7
Altered Gut Microbiota and Plasma Metabolome Profiles Characterize Depression Individuals with Ischemic Stroke: A Comparative Analysis.肠道微生物群和血浆代谢组学特征改变:缺血性脑卒中抑郁症患者的比较分析
Neuropsychiatr Dis Treat. 2025 Apr 29;21:973-987. doi: 10.2147/NDT.S513364. eCollection 2025.
8
Cancer chemoprevention: signaling pathways and strategic approaches.癌症化学预防:信号通路与策略方法
Signal Transduct Target Ther. 2025 Apr 18;10(1):113. doi: 10.1038/s41392-025-02167-1.
9
Dietary supplementation with farnesol confers a protective effect on the intestine of broiler chickens challenged with lipopolysaccharide by reshaping intestinal flora structure and regulating TLR4/NF-κB signaling pathway.用法尼醇进行膳食补充,通过重塑肠道菌群结构和调节TLR4/NF-κB信号通路,对受到脂多糖攻击的肉鸡肠道具有保护作用。
Poult Sci. 2025 Apr;104(4):104942. doi: 10.1016/j.psj.2025.104942. Epub 2025 Feb 23.
10
Gut Microecological Prescription: A Novel Approach to Regulating Intestinal Micro-Ecological Balance.肠道微生态处方:调节肠道微生态平衡的新方法。
Int J Gen Med. 2025 Feb 5;18:603-626. doi: 10.2147/IJGM.S504616. eCollection 2025.